SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-14-002564
Filing Date
2014-08-06
Accepted
2014-08-06 08:02:04
Documents
5
Period of Report
2014-08-06

Document Format Files

Seq Description Document Type Size
1 6-K zk1415369.htm 6-K 12780
2 PRESS RELEASE exhibit_1.htm EX-99 309724
3 UNAUDITED FINANCIAL STATEMENTS exhibit_2.htm EX-99 480284
4 OPERATING AND FINANCIAL REVIEW exhibit_3.htm EX-99 241494
5 bioline.jpg GRAPHIC 10875
  Complete submission text file 0001178913-14-002564.txt   1060488
Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 141018117
SIC: 2834 Pharmaceutical Preparations